Fountain Life received the Roundtable of Longevity Clinics' Longevity Clinic of the Year 2026 designation, citing a longitudinal dataset of more than 15 billion clinical data points from over 8,000 members. Reported member outcomes include coronary plaque halting in 26% and regression in 6%, return to normal glucose regulation in 51% of those with prediabetes within an average of 1.2 years, and MRI-confirmed resolution in 52% of fatty liver cases.
Key Points
- 26% of members halted coronary plaque progression; 6% regressed
- 51% of prediabetic members normalized blood sugar within 1.2 years
- MRI confirmed fatty liver resolution in 52% of cases
Longevity Analysis
Dense baseline measurement — coronary plaque imaging, brain MRI, whole genome sequencing, over 100 biomarkers, microbiome analysis, VO2 max — converts vague risk into specific, trackable signals, and the reported reversal rates indicate those signals respond to sustained intervention rather than remaining fixed. Arterial plaque, hepatic fat accumulation, glucose regulation and accelerated brain aging are not isolated endpoints; they reflect overlapping metabolic, circulatory and clearance processes that shift together when the underlying drivers are addressed. The 1.2-year average to glycemic normalization is the operative detail: measurable structural change requires repeated follow-up and adherence over quarters, not weeks.
Original published by LT Wire.